STOCK TITAN

Healthcare Services Group (HCSG) COO sells 15,598 shares of stock

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Healthcare Services Group Inc. executive Andrew Kush, EVP & Chief Operating Officer, reported a sale of 15,598 shares of common stock on 2026-08-04 at a weighted average price of $23.24 per share in an open-market or private transaction. Following this sale, he directly holds 22,741 shares of common stock. A footnote explains the sale was executed in multiple trades and that the reported price is a weighted average; detailed trade‑level prices and share amounts are available upon request. The Form 4 indicates the transaction was not made under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Kush Andrew
Role EVP & Chief Operating Officer
Sold 15,598 shs ($362K)
Type Security Shares Price Value
Sale Common Stock F1 15,598 $23.24 $362K
Holdings After Transaction: Common Stock — 22,741 shares (Direct)
Footnotes (1)
  1. F1. This transaction was executed in multiple trades. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares sold 15,598 shares Common stock sale reported on 2026-08-04
Weighted average sale price $23.24 per share Weighted average sales price for the reported transaction
Shares held after transaction 22,741 shares Direct common stock ownership following the sale
weighted average sales price financial
"The price reported above reflects the weighted average sales price."
open market or private transaction financial
"Transaction code description: Sale in open market or private transaction."
Rule 10b5-1 trading plan regulatory
"The transaction was not indicated as made under a Rule 10b5-1 trading plan."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Andrew Kush report for HCSG?

Andrew Kush, EVP & Chief Operating Officer, reported selling 15,598 shares of Healthcare Services Group common stock at a weighted average price of $23.24 per share, leaving him with 22,741 shares directly held after the transaction.

At what price were the HCSG shares sold in Andrew Kush’s Form 4?

The reported transaction used a $23.24 per share weighted average sales price. A footnote states the sale occurred in multiple trades and that full details of individual prices and share amounts are available upon request from the issuer, SEC staff, or security holders.

How many HCSG shares does Andrew Kush hold after this Form 4 sale?

After selling 15,598 shares, Andrew Kush directly holds 22,741 shares of Healthcare Services Group common stock. This post‑transaction holding figure is reported in the Form 4 as his direct ownership following the 2026-08-04 sale.

Was Andrew Kush’s HCSG stock sale under a Rule 10b5-1 plan?

The Form 4 indicates the transaction was not made under a Rule 10b5-1 trading plan. The document-level checkbox for Rule 10b5-1 is shown as unchecked, and no footnote describes the sale as occurring pursuant to such a pre‑arranged plan.

What type of transaction did the HCSG Form 4 report for Andrew Kush?

The Form 4 reports a sale of common stock classified as an open market or private transaction. It is coded as transaction type “S,” with 15,598 non-derivative shares sold directly and no derivative exercises or gifts reported in this filing.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kush Andrew

(Last)(First)(Middle)
3220 TILLMAN DRIVE
SUITE 300

(Street)
BENSALEM PENNSYLVANIA 19020

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/04/202608/04/2026S15,598D$23.24(1)22,741D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was executed in multiple trades. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks:
Michael Harrity, by Power of Attorney08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)